Skip to main content

Table 1 Select self-report participant characteristics at initial iOAT entry

From: Building healthcare provider relationships for patient-centered care: A qualitative study of the experiences of people receiving injectable opioid agonist treatment

CharacteristicsN = 30
M ± SD; n (%)
Socio-demographic characteristics
 Age44.7 ± 8.7
 Women14 (46.7)
 Any Indigenous vs. Non-Indigenous ancestry a7 (23.3)
 Any non-stable housing in prior 3 years vs. none19 (63.3)
 Any street housing in prior 3 years vs. none6 (20.00)
  Less than high-school certificate10 (33.3)
  High school certificate7 (23.3)
  High school certificate and higher (e.g., trades, university)13 (43.3)
Health status
 Physical health score b13.8 ± 8.0
 Psychological health score b9.5 ± 8.0
 Health related quality of life score c0.8 ± 0.2
Susbstance use and substance use treatment history
 Lifetime years heroin injection14.5 ± 8.6
 Times ever attempted medication assisted treatment with oral methadone4.2 ± 2.6
 Highest daily dose of oral methadone in mgs d106.7 ± 51.9
 Ever enrolled in outpatient withdrawal28 (93.3)
 Ever in outpatient counseling23 (76.7)
 Ever enrolled in residential treatment17 (56.7)
  1. Data shown are mean ± standard deviation; N (%)
  2. aAboriginal ancestry includes participants who self-identified as Inuit, Metis, or First Nations.
  3. bMAP Physical and Psychological health scores range from 0 to 40 with higher scores indicating poorer health.
  4. cEQ5D (Euroquol) with Canadian weights scores range from 0 to 1; higher scores are indicative of better health status.
  5. dBased on administrative prescription records data from 1995 to 2012.